Cystic fibrosis: a clinical and nutritional approach
Keywords:
Malnutrition, Cystic fibrosis, Nutrition therapyAbstract
Cystic fibrosis is the most common, lethal, genetic disease in Caucasian populations and is characterized by chronic and recurrent lung infections, pancreatic insufficiency and high sweat chloride levels. It is an autosomal recessive hereditary disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator gene which induces the body to produce thick and viscous mucus secretions that obstruct the lungs, pancreas and bile duct. Many patients have pancreatic insufficiency which leads to malabsorption of nutrients, especially proteins and fats and to gastrointestinal complications such as rectal prolapse, intestinal obstruction syndrome, constipation and hepatic cirrhosis. Cystic fibrosis is usually diagnosed during childhood by neonatal screening programs or sweat test. Because of the multiple systems involved and the variability and chronicity of the disease, a multidisciplinary team is essential to help patients and their families understand the disease and adhere to treatment. Current cystic fibrosis therapy includes maintaining the nutritional status, clearing the airways with physiotherapy and mucolytics, preventing and treating infections with antibiotics and prescribing energy supplements, high-fat and high-protein diets, as well as minerals and fat-soluble vitamins. The purpose of this study was to present a brief literature review of the clinical and nutritional aspects of cystic fibrosis.
References
Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002; 15(2):194-222.
Bentley P. Undeerstanding cystic fibrosis, improving life expectancy. Nurs Times. 1999; 95(43):50-61.
Morison S, Dodge JA, Cole TJ, Lewis PA, Coles EC, Geddes D, et al. Height and weight in cystic fibrosis: a cross sectional study. Arch Dis Child. 1997; 77(6): 427-500.
Adde FV, Rodrigues JC, Cardoso AL. Seguimento nutricional de pacientes com fibrose cística: papel do aconselhamento nutricional. J Ped. 2004; 80(6):475-82.
Ribeiro JD, Ribeiro MAGO, Ribeiro AF. Controvérsias na fibrose cística: do pediatra ao especialista. J Ped. 2002; 78(supl.2):171-86.
Balinsky W, Zhu CW. Pediatric cystic fibrosis: evaluating cost and genetic testing. J Pediatr Health Care. 2004; 18(1):30-4.
Pereira L, Raskin S, Freund AA, Ribas PD, Castro RMV, Pignatti PF, et al. Cystic fibrosis mutations R1162X and 2183AA!G in two Southern Brazilian states. Genet Mol Biol. 1999; 22(3):291-4.
Raskin S, Philips JA, Krishnamani MR, VnencakJones C, Parler RA, Dawson E, et al. Regional distributions of cystic fibrosis-linked DNA halotypes in Brazil: multicenter study. Hum Biol. 1997; 69(1):75-8.
Collins CE, MacDonald-Wicks L, Rowe S, O´Loughlin EV, Henry RL. Normal growth in cystic fibrosis associated with a specialized center. Arch Dis Child. 1999; 81(3):241-6.
Mickie JE, Cutting GR. Clinical implications of cystic fibrosis transmembrane conduntance regulator mutations. Clin Chest Med. 1998; 19(3):443-58.
Fiates GMR, Barbosa E, Auler F, Feiten SF, Miranda F. Estado nutricional e ingestão alimentar de pessoas com fibrose cística. Rev Nut. 2001; 14(2):95-101.
Lemos AC, Matos E, Franco R, Santana P, Santana MA. Fibrose cística em adultos: aspectos clínicos e espirométricos. J Bras Pneumol. 2004; 30(1):9-13.
Brasil. Portaria SAS/MS nº 338 de 29 de junho de 2005. Brasília; 2005 [acesso 2007 ago 15]. Disponível em: <http://dtr2001.saude.gov.br/sas/PORTARIAS/Port2005/PT-338.htm>.
Helms PJ. Growing up with cystic fibrosis. Br J Hosp Med. 1998; 50(6):326-32.
Reis FJC, Oliveira MCL, Penna FJ, Oliveira MGR, Oliveira EA, Monteiro APAF. Quadro clínico e nutricional de pacientes com fibrose cística: 20 anos de seguimento no HC-UFMG. Rev Assoc Med Brasil. 2000; 46(4):325-30.
Fibrose cistica: tudo sobre esta patologia [acesso 2008 maio 31]. Disponível em: <http://www.fibrosecistica.com/fibrosecisticaprognostico.html>.
Alvarez A, Ribeiro AF, Hessel G, Bertuzzo CS, Ribeiro JD. Fibrose cística em um centro de referência no Brasil: características clínicas e laboratoriais de 104 pacientes e sua associação com o genótipo e a gravidade da doença. J Ped. 2004; 80(5):371-9.
Camargos PAM, Guimarães MDC, Reis FC. Prognostic aspects of cystic fibrosis in Brazil. Ann Trop Pediatr. 2000; 20(4):287-91.
Green MR, Buchanan E, Weaver LT. Nutritional management of the infant with cystic fibrosis. Arch Dis Child. 1995; 72(5):452-6.
Cabello GMK, Cabello PH, Roig SRS, Fonseca A, Carvalho ECD, Fernandes O. Rastreamento da fibrose cística usando-se a análise combinada do teste de IRT neonatal e o estudo molecular da mutação DF508. J Bras Patol Med Lab. 2003; 39(1): 15-20.
Silva Filho LVF, Bussamra MHCF, Nakaie CMA. Fibrose cística com dosagem de cloro no suor normal: relato de caso. Rev Hosp Clin. 2003; 58(5): 260-2.
Dowsett J. An overview of nutritional issues for the adult with cystic fibrosis. Nutrition. 2000; 16(7/ 8):566-70.
Dallalana LT. Fibrose cística. In: Tarantino AB. Doenças pulmonares. 5a. ed. São Paulo: Guanabara Koogan; 2002. p.624-40.
Andrade EF, Fonseca DLO, Silva FAA, Menna-Barreto SS. Avaliação evolutiva da espirometria na fibrose cística. J Bras Pneum. 2001; 27(3):130-6.
Magalhães M, Britto MCA, Becerra PGM, Veras A. Prevalência de bactérias potencialmente patogênicas em espécimes respiratórias de fibrocístico do Recife. J Bras Pat Med Lab. 2004; 40(4):223-7.
Raymond NC, Chang PN, Crow SJ, Mitchell JE, Dieperink BS, Beck MM, et al. Eating disorders in patients with cystic fibrosis. J Adolesc. 2000; 23(3): 359-63.
Evans AK, Fitzgerald DA, Mckay KO. The impact of meconium ileus on the clinical course of children with cystic fibrosis. Eur Respir J. 2001; 18(5):784-9.
Wood LG, Gibson PG, Garg ML. Circulating markers to assess nutritional therapy in cystic fibrosis. Clin Chim Acta. 2005; 353(1/2):13-29.
Kalivianakis M, Minich DM, Bijleveld CM, van Aalderen WM, Stellaard F, Laseur M, et al. Fat malabsorption in cystic fibrosis receiving enzyme replacement therapy is due to impaired intestinal uptake of long chain fatty acids. Am J Clin Nutr. 1999; 69(1):127-34.
Creveling S, Light M, Gardner P, Greene L. Cystic fibrosis, nutrition, and the health care team. J Am Diet Assoc. 1997; 97(10 Suppl 2):S186-91.
Donald AM. Nutritional management of cystic fibrosis. Arch Dis Child. 1996; 74(1):81-7.
Ramsey BW, Farrell PM, Pencharz P. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nut. 1992; 55(1): 108-16.
Ward SA, Tomezsko JL, Holsclaw DS, Paolone AM. Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus. Am J Clin Nutr. 1999; 69(5):913-9.
Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HGM, et al. Nutrition in patients with cystic fibrisis: a European Consensus. J Cyst Fibros. 2002; 1(2):51-75.
Burdet L, Hugli O, Aubert JD, Schutz Y, Roulet M, Fitting JW. Effect of elective antibiotic therapy on resting energy expenditure and infection in patients with cystic fibrosis. Eur J Pediatr. 1999; 158(9):711-6.
Fagundes EDT, Silva RAP, Roquete MLV, Penna FJ, Reis FJC, Goulart EMA, et al. Validação do escore ultra-sonográfico de Williams para o diagnóstico da hepatopatia da fibrose cística. J Pediatr (Rio de Janeiro). 2004; 80(5):380-6.
Sokol RJ, Durie PR. Recommendations for managment of liver and biliary tract disease in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1999; 28(Suppl 1):S1-13.
Hamer L, Parker HW. Treatment of cystic fibrosis in adults. Am Fam Physician. 1996; 54(4):1291-7.
Moreira RO, Duarte MPC, Farias MLF. Distúrbios do eixo cálcio-PTH-vitamina D nas doenças hepáticas crônicas. Arq Bras End Met. 2004; 48(4): 443-50.
Elkin SL, Fairney A, Burnett S, Kemp M, Kyd P, Burgess J, et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a crosssectional study. Osteoporos Int. 2001; 12(5): 366-72.
Allison JLS. Management of adolescent and adult inpatients with cystic fibrosis. Am J Health Syst Pharm. 1999; 56(2):158-60.
Richardson I, Nyulasi I, Cameron K, Ball M, Wilson J. Nutritional status of an adult cystic fibrosis population. Nutrition. 2000; 16(4):255-9.
Minas Gerais. Resolução SES nº 1088 de 29 de dezembro de 2006. Institui a Rede Estadual de Atenção à Saúde do Portador de Fibrose Cística. Belo Horizonte; 2006 [acesso 2007 ago 15]. Disponível em: .
Conselho Nacional de Secretaria da Saúde de Minas Gerais. SES/MG - Minas busca diagnosticar pessoas que não sabem que tem doença rara [acesso 2008 maio 31]. Disponível em: <http://www.conass.org.br/page=noticias_estados&codigo=1761&i=0&mesAtual=04&anoAtual=2006&diaAtual=06>.
Vivendo com a fibrose cística. [acesso 31 maio 2008]. Disponível em: <http://www.gbefibrosecística.org.br/>.
Brasil. SAS/MS nº 263, de 18 de julho de 2001. Fibrose cística: enzimas pancreáticas. Brasília; 2001 [acesso 2005 jul]. Disponível em: <http://www.saude.gov.br>.
Sharma M, Singh M. Nutritional management of children with cystic fibrosis. Ind Ped. 2003; 40(11): 1055-62.
MacDonald A. The diet in cystic fibrosis: why is it important? Curr Paed. 2000; 10(3):155-61.
Koletzko S, Reinhardt D. Nutritional challenges of infants with cystic fibrosis. Early Hum Dev. 2001; 65(Suppl 2):S53-61.
Wilson DC, Pencharz PB. Nutrition and cystic fibrosis. Nutrition. 1998; 14(10):792-3.
Feranchak AP, Sontag MK, Wagener JS, Hammond KB, Accurso FJ, Sokol RJ. Prospective long-term study of fat-soluble vitamin status in children with cystic fibrosis diagnosed by newborn screen. J Pediatr. 1999; 135(5):601-10.
Reiter EO, Brugman SM, Pike JW, Pitt M, Dokoh S, Haussler MR, et al. Vitamin D metabolites in adolescents and young adults with cystic fibrosis: effects of sun and season. J Pediatr. 1985; 106(1): 21-6.
Thompson GN. Determinants of serum vitamin D levels in preadolescent cystic fibrosis children. Acta Paediatr Scand. 1987; 76(6):962-5.
Vieth R. Problems with direct 25-hidroxyvitamin D assays, and the target amount of vitamin D nutrition desirable for patients with osteoporosis. Osteoporos Int. 2000; 11(7):553-5.
Winklhofer-Roob BM, van’t Hof MA, Shmerling DH. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations. Am J Clin Nutr. 1996; 63(5):722-8.
Easley D, Krebs N, Jefferson M, Miller L, Erskine J, Accurso F, et al. Effect of pancreatic enzyme on zinc absorption in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1998; 26(2):136-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Fernanda Ribeiro ROSA, Fernanda Gomes DIAS, Luciana Neri NOBRE, Harriman Aley MORAIS
This work is licensed under a Creative Commons Attribution 4.0 International License.
